Fisiopatología e Investigación Clínica de las Enfermedades de Base Inmunológica e Inflamatoria Crónicas

de la Aleja, AG; Herrero, C; Torres-Torresano, M; Schiaffino, MT; del Castillo, A; Alonso, B; Vega, MA; Puig-Kroger, A; Castrillo, A; Corbi, AL.

Inhibition of LXR controls the polarization of human inflammatory macrophages through upregulation of MAFB

CELLULAR AND MOLECULAR LIFE SCIENCES. 2023; 80(4): Nº de citas: 5 [doi:10.1007/s00018-023-04745-4]

Suarez-Trujillo, F; Juarez, I; Recio-Hoyas, MJ; Rey, D; Palacio-Gruber, J; Gil-Martin, R; Martin-Villa, JM; Arnaiz-Villena, A.

HLA-DMB alleles and haplotypes in Ecuador (Cuenca) Amerindians: Importance for HLA and disease studies

HUMAN IMMUNOLOGY. 2023; 84(4): 261-262 Nº de citas: 1 [doi:10.1016/j.humimm.2023.02.004]

Rodriguez-Ruiz, ME; Serrano-Mendioroz, I; Garate-Soraluze, E; Sanchez-Mateos, P; Barrio-Alonso, C; Lopez, IR; Pascual, VD; Moreno, LA; Alvarez, M; Sanmamed, MF; Perez-Gracia, JL; Escuin-Ordinas, H; Quintero, M; Melero, I.

Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control

Journal for ImmunoTherapy of Cancer. 2023; 11(1): Nº de citas: 9 [doi:10.1136/jitc-2022-005011]

Kotton CN; Torre-Cisneros J; Aguado JM; Alain S; Baldanti F; Baumann G; Boeken U; de la Calle M; Carbone J; Ciceri F; Comoli P; Couzi L; Danziger-Isakov L; Fernández-Ruiz M; Girmenia C; Grossi PA; Hirsch HH; Humar A; Kamar N; Kotton C; Ljungman P; Malagola M; Mira E; Mueller N; Sester M; Teng CJ; Torre-Cisneros J; Ussetti P; Westall G; Wolf D; Zamora M.

Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021

TRANSPLANT INFECTIOUS DISEASE. 2022; 24(6): Nº de citas: 38 [doi:10.1111/tid.13977]

Aguinaga-Barrilero, A; Juarez, I; Vaquero-Yuste, C; Molina-Alejandre, M; Gutierrez-Calvo, A; Lasa, I; Lopez, A; Gomez, R; Molanes-Lopez, EM; Martin-Villa, JM.

Higher prevalence of LAP plus (Latency TGF beta-Associated Peptide) T cells at the tissue level in patients with early gastric cancer

CELLULAR IMMUNOLOGY. 2022; 382: Nº de citas: 2 [doi:10.1016/j.cellimm.2022.104635]

Rios, I; Lopez-Navarro, B; Torres-Torresano, M; Palacios, BS; Simon-Fuentes, M; Dominguez-Soto, A; Muller, IB; Jansen, G; Corbi, AL; Puig-Kroger, A.

GSK3 beta Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate

JOURNAL OF INNATE IMMUNITY. 2022; 15(1): 1-14 Nº de citas: 4 [doi:10.1159/000526622]

Santos-Coquillat, A; Herreros-Perez, D; Samaniego, R; Gonzalez, MI; Cusso, L; Desco, M; Salinas, B.

Dual-labeled nanoparticles based on small extracellular vesicles for tumor detection

BIOLOGY DIRECT. 2022; 17(1): Nº de citas: 8 [doi:10.1186/s13062-022-00345-7]

Suarez-Trujillo F; Rey D; Bendukidze N; Juarez I; Sanchez-Orta A; Palacio-Gruber J; Manuel Martin-Villa J; Arnaiz-Villena A.

Class II HLA in Georgia Caucasus Tbilisi Georgians and their Mediterranean ancestry: The Usko Mediterranean languages

HUMAN IMMUNOLOGY. 2022; 83(11): 739-740 Nº de citas: 1 [doi:10.1016/j.humimm.2022.08.005]

Vilchez-Oya, F; Martin, HB; Garcia-Martinez, E; Corominas, H.

Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjogren's syndrome: A critical review

Frontiers in Immunology. 2022; 13: Nº de citas: 5 [doi:10.3389/fimmu.2022.1003054]

Holland, TL; Ginde, AA; Paredes, R; Murray, TA; Engen, N; Grandits, G; Vekstein, A; Ivey, N; Mourad, A; Sandkovsky, U; Gottlieb, RL; Berhe, M; Jain, MK; Marines-Price, R; Agbor, BTA; Mateu, L; Espana-Cueto, S; Llados, G; Mylonakis, E; Rogers, R; Shehadeh, F; Filbin, MR; Hibbert, KA; Kim, K; Tran, T; Morris, PE; Cassity, EP; Trautner, B; Pandit, LM; Knowlton, KU; Leither, L; Matthay, MA; Rogers, AJ; Drake, W; Jones, B; Poulakou, G; Syrigos, KN; Fernandez-Cruz, E; Di Natale, M; Almasri, E; Balerdi-Sarasola, L; Bhagani, SR; Boyle, KL; Casey, JD; Chen, P; Douin, DJ; Files, DC; Gunthard, HF; Hite, RD; Hyzy, RC; Khan, A; Kibirige, M; Kidega, R; Kimuli, I; Kiweewa, F; Jensen, JU; Leshnower, BG; Lutaakome, JK; Manian, P; Morales-Rull, JL; O'Mahony, DS; Overcash, JS; Ramachandruni, S; Steingrub, JS; Taha, HS; Waters, M; Young, BE; Phillips, AN; Murray, DD; Jensen, TO; Padilla, ML; Sahner, D; Shaw-Saliba, K; Dewar, RL; Teitelbaum, M; Natarajan, V; Rehman, MT; Pett, S; Hudson, F; Touloumi, G; Brown, SM; Self, WH; Chang, CC; Sanchez, A; Weintrob, AC; Hatlen, T; Grund, B; Sharma, S; Reilly, CS; Garbes, P; Esser, MT; Templeton, A; Babiker, AG; Davey, VJ; Gelijns, AC; Higgs, ES; Kan, V; Matthews, G; Thompson, BT; Neaton, JD; Lane, C; Lundgren, JD.

Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase atrial

Lancet Respiratory Medicine. 2022; 10(10): 972-984 Nº de citas: 86 [doi:10.1016/S2213-2600(22)00215-6]

Arnaiz-Villena, A; Suarez-Trujillo, F; Juarez, I; Rodriguez-Sainz, C; Palacio-Gruber, J; Vaquero-Yuste, C; Molina-Alejandre, M; Fernandez-Cruz, E; Martin-Villa, JM.

Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes

CELLULAR AND MOLECULAR LIFE SCIENCES. 2022; 79(8): Nº de citas: 10 [doi:10.1007/s00018-022-04491-z]

Sevilla-Movilla, S; Fuentes, P; Rodriguez-Garcia, Y; Arellano-Sanchez, N; Krenn, PW; de Val, SI; Montero-Herradon, S; Garcia-Ceca, J; Burdiel-Herencia, V; Gardeta, SR; Aguilera-Montilla, N; Barrio-Alonso, C; Crainiciuc, G; Bouvard, D; Garcia-Pardo, A; Zapata, AG; Hidalgo, A; Fassler, R; Carrasco, YR; Toribio, ML; Teixido, J.

ICAP-1 loss impairs CD8(+) thymocyte development and leads to reduced marginal zone B cells in mice

EUROPEAN JOURNAL OF IMMUNOLOGY. 2022; 52(8): 1228-1242 [doi:10.1002/eji.202149560]

Llorente, V; Sanderson, D; Martin-Gorgojo, A; Samaniego, R; Desco, M; Gomez-Gaviro, MV.

A 3D Analysis of Cleared Human Melanoma

Biomedicines. 2022; 10(7): Nº de citas: 3 [doi:10.3390/biomedicines10071580]

Arnaiz-Villena, A; Longas, J; Rodriguez-Sainz, C; Gomez-Casado, E; Palacio-Gruber, J; Luna, F; del Moral, P; Suarez-Trujillo, F.

HLA in Las Alpujarras Mts., South-East Spain: A Renaissance process of population artificial substitution

HUMAN IMMUNOLOGY. 2022; 83(6): 480-481 Nº de citas: 1 [doi:10.1016/j.humimm.2022.03.0090198-8859]

.

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial.

LANCET INFECTIOUS DISEASES. 2022; 22(5): 622-635 Nº de citas: 77 [doi:10.1016/S1473-3099(21)00751-9]

Cuevas, VD; Simon-Fuentes, M; Orta-Zavalza, E; Samaniego, R; Sanchez-Mateos, P; Escribese, M; Cimas, FJ; Bustos, M; Perez-Diego, M; Ocana, A; Dominguez-Soto, A; Vega, MA; Corbi, AL.

The Gene Signature of Activated M-CSF-Primed Human Monocyte-Derived Macrophages Is IL-10-Dependent

JOURNAL OF INNATE IMMUNITY. 2022; 14(3): 243-256 Nº de citas: 13 [doi:10.1159/000519305]

Rodriguez-Lomba, E; Garcia-Piqueras, P; Lozano-Masdemont, B; Nieto-Benito, LM; de la Torre, EH; Parra-Blanco, V; Suarez-Fernandez, R; Lazaro-Ochaita, P; Aviles-Izquierdo, JA.

'Rainbow pattern': a dermoscopic sign of invasive melanoma

CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2022; 47(3): 529-533 Nº de citas: 7 [doi:10.1111/ced.14950]

Gutiérrez-Seijo A; García-Martínez E; Barrio-Alonso C; Parra-Blanco V; Avilés-Izquierdo JA; Sánchez-Mateos P; Samaniego R.

Activin A Sustains the Metastatic Phenotype of Tumor-Associated Macrophages and Is a Prognostic Marker in Human Cutaneous Melanoma

JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2022; 142(3 PT A): 653 Nº de citas: 6 [doi:10.1016/j.jid.2021.07.179]